SCR-LIP-000232 · Claim · machine-readable JSON →

This review synthesizes evidence that estrogen and its receptors (ERα, ERβ, GPER) influence lipedema pathogenesis, noting disease onset/aggravation during hormonal-fluctuation windows (puberty, pregnancy, menopause) and that altered ER expression in gluteofemoral subcutaneous adipose tissue (reduced ERα, increased ERβ) parallels the regional fat accumulation characteristic of lipedema, affecting ~11% of women.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
very low (GRADE)
Evidence
1 source(s)
Dates
2026-05-31 → 2026-05-31

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

2021Estrogen as a Contributing Factor to the Development of Lipedema — Al-Ghadban et al. (2021) · consistent

Evidence (1)

Context (PECO)

Populationwomen with lipedema (~11% prevalence)
Conditionlipedema
Exposureestrogen signaling via ERα, ERβ, GPER
Comparatornormal gluteofemoral adipose tissue ER expression
Outcomeregional fat accumulation and disease onset/aggravation
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log